Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01303796
Title A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (SEAMLESS)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Cyclacel Pharmaceuticals, Inc.

acute myeloid leukemia


Decitabine + Sapacitabine


Age Groups: senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

No variant requirements are available.